Aptose Biosciences Inc
NASDAQ:APTO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
Thor Industries Inc
NYSE:THO
|
US |
|
A
|
AAPICO Hitech PCL
SET:AH
|
TH |
|
COPT Defense Properties
NYSE:CDP
|
US |
|
Awilco LNG ASA
OSE:ALNG
|
NO |
|
Babcock & Wilcox Enterprises Inc
NYSE:BW
|
US |
|
Canadian Tire Corporation Ltd
TSX:CTC.A
|
CA |
|
New York Times Co
NYSE:NYT
|
US |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
JCDecaux SA
OTC:JCDXF
|
FR |
|
IQVIA Holdings Inc
NYSE:IQV
|
US |
|
Kairos Minerals Ltd
ASX:KAI
|
AU |
|
Bloom Energy Corp
NYSE:BE
|
US |
|
E
|
Eiffage SA
SWB:EF3
|
FR |
|
Delek Logistics Partners LP
NYSE:DKL
|
US |
|
Banco Bilbao Vizcaya Argentaria SA
MAD:BBVA
|
ES |
|
Central Security Patrols Co Ltd
TSE:9740
|
JP |
|
Canon Electronics Inc
TSE:7739
|
JP |
|
Deere & Co
NYSE:DE
|
US |
|
US Energy Corp
NASDAQ:USEG
|
US |
|
Duluth Holdings Inc
NASDAQ:DLTH
|
US |
|
CESC Ltd
NSE:CESC
|
IN |
|
S
|
Stainless Tankers ASA
OSE:STST
|
NO |
Bankruptcy Probability
Aptose Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptose Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
5.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptose Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptose Biosciences Inc has total debt of 10m USD. This includes both short-term (0 USD) and long-term (10m USD) debt.
You can find a full breakdown on its Balance Sheet.
